# Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer

> **NCT02042859** · PHASE1 · UNKNOWN · sponsor: **Ochsner Health System** · enrollment: 40 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** Endoscopic Bipolar RadioFrequency Probe used to remove tumors in bile duct to manage Pancreatic Cancer

## Key facts

- **NCT ID:** NCT02042859
- **Lead sponsor:** Ochsner Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042859, "Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02042859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*